March is National Kidney Month, which makes this a good time to learn more about the difference between two kidney disorders—kidney cysts and polycystic kidney disease. Your kidneys are situated in ...

MIT researchers including Robert Croy (left) and Bogdan Fedeles have discovered that a drug they originally developed as a potential cancer treatment may also hold promise in treating autosomal ...

Polycystic kidney disease (PKD) is a genetic disorder marked by the growth of many fluid-filled sacs (cysts) in your kidneys. These cysts can grow to replace normal kidney tissue over time, leading to ...

Autosomal dominant polycystic kidney disease (ADPKD), the most common form of polycystic kidney disease, can lead to kidney enlargement and eventual loss of function. The disease affects more than 12 ...

Polycystic kidney disease (PKD) is a common genetic disorder, and it's thought to affect over 12 million people every year. PKD causes fluid filled cysts to form in the kidney, causing pain and high ...

Polycystic kidney disease (PKD) is a debilitating hereditary condition in which fluid-filled sacs form and proliferate in the kidneys. Over time, the painful, growing cysts rob the organs of their ...

Blocking the inhibition of PKD1 and PKD2 gene expression by deleting a binding site for microRNAs hindered the formation and growth of kidney cysts in autosomal dominant polycystic kidney disease ...

Cystic renal cell carcinoma is a rare type of cancer. A person may develop cystic renal cell carcinoma if they have treatment for the last stages of kidney failure. Cystic renal cell carcinoma (CRCC) ...

The global polycystic kidney disease (PKD) market is expanding rapidly due to rising prevalence, advanced treatments, and increased awareness. The growing cases of chronic kidney diseases (CKD) ...